Chemokines kill bacteria without triggering antimicrobial resistance by binding anionic phospholipids
Science Advances · 2025
DOI: 10.1126/sciadv.ads2675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Sergio M Pontejo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Chemokines, Escherichia coli, Phospholipids, Drug Resistance, Bacterial. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Classically, chemokines coordinate leukocyte trafficking; however, many chemokines also have direct antibacterial activity. The bacterial killing mechanism of chemokines and the biochemical properties that define which members of the chemokine superfamily are antimicrobial remain poorly understood. We report that the antimicrobial activity of chemokines is defined by their ability to bind phosphatidylglycerol and cardiolipin, two anionic phospholipids commonly found in the bacterial plasma membrane. We show that only chemokines able to bind these two phospholipids kill bacteria and that they exert rapid bacteriostatic and bactericidal effects with a higher potency than the antimicrobial peptide β-defensin 3. Both biochemical and genetic interference with the chemokine-cardiolipin interaction impaired microbial growth arrest, bacterial killing, and membrane disruption by chemokines. Moreover, unlike conventional antibiotics, Escherichia coli failed to develop resistance when placed under increasing antimicrobial chemokine pressure in vitro. Thus, we have identified cardiolipin and phosphatidylglycerol as binding partners for chemokines responsible for chemokine antimicrobial action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- Structural Biology Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA 90095, USA.
- Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA 90095, USA.
- Department of Microbiology, Immunology & Molecular Genetics, University of California Los Angeles, Los Angeles, CA 90095, USA.
- California NanoSystems Institute, University of California Los Angeles, Los Angeles, CA 90095, USA.
ORCID-Profile: Sergio M Pontejo, Sophia Martinez, Allison Zhao, Kevin Barnes, Jaime de Anda, Haleh Alimohamadi, Ernest Y Lee, Brian F Volkman, Gerard C L Wong, David N Garboczi, Angela Ballesteros, Philip M Murphy
Förderung
- NIAID NIH HHS
Zitieren
APA
Pontejo, S. M., Martinez, S., Zhao, A., Barnes, K., de Anda, J., Alimohamadi, H., Lee, E. Y., Dishman, A. F., Volkman, B. F., Wong, G. C. L., Garboczi, D. N., Ballesteros, A., & Murphy, P. M. (2025). Chemokines kill bacteria without triggering antimicrobial resistance by binding anionic phospholipids. Science Advances. https://doi.org/10.1126/sciadv.ads2675
Vancouver
Pontejo SM, Martinez S, Zhao A, Barnes K, de Anda J, Alimohamadi H, et al. Chemokines kill bacteria without triggering antimicrobial resistance by binding anionic phospholipids. Science Advances. 2025. doi:10.1126/sciadv.ads2675
BibTeX
@article{Pontejo2025,
author = {Pontejo, Sergio M and Martinez, Sophia and Zhao, Allison and Barnes, Kevin and de Anda, Jaime and Alimohamadi, Haleh and Lee, Ernest Y and Dishman, Acacia F and Volkman, Brian F and Wong, Gerard C L and Garboczi, David N and Ballesteros, Angela and Murphy, Philip M},
title = {Chemokines kill bacteria without triggering antimicrobial resistance by binding anionic phospholipids},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.ads2675}
}
EUVIMED